In a welcome move, Curtiss-Wright saw its Relative Strength Rating rise from 68 to 74 on Thursday.
IBD's proprietary rating tracks price performance with a 1 (worst) to 99 (best) score. The rating shows how a stock's price behavior over the trailing 52 weeks holds up against all the other stocks in our database.
History reveals that the stocks that go on to make the biggest gains tend to have an 80 or higher RS Rating as they launch their biggest climbs. See if Curtiss-Wright can continue to rebound and clear that threshold.
When To Sell Stocks To Lock In Profits And Minimize Losses
Curtiss-Wright has risen more than 5% past a 286.65 entry in a second-stage flat base, meaning it's now out of a proper buy range. Look for the stock to offer a new buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week moving average.
The company showed 3% earnings growth in the latest quarterly report, while sales growth came in at 5%.
The company holds the No. 17 rank among its peers in the Aerospace/Defense industry group. Embraer ADR, Howmet Aerospace and OSI Systems are among the top 5 highly rated stocks within the group.
RELATED:
Defense And Aerospace Stocks To Watch And Industry News
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
